Bactiguard Holding AB (publ)
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more
Bactiguard Holding AB (publ) (BACTI-B) - Net Assets
Latest net assets as of December 2025: Skr314.93 Million SEK
Based on the latest financial reports, Bactiguard Holding AB (publ) (BACTI-B) has net assets worth Skr314.93 Million SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr545.06 Million) and total liabilities (Skr230.13 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr314.93 Million |
| % of Total Assets | 57.78% |
| Annual Growth Rate | 0.15% |
| 5-Year Change | -41.84% |
| 10-Year Change | -19.32% |
| Growth Volatility | 66.65 |
Bactiguard Holding AB (publ) - Net Assets Trend (2008–2025)
This chart illustrates how Bactiguard Holding AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bactiguard Holding AB (publ) (2008–2025)
The table below shows the annual net assets of Bactiguard Holding AB (publ) from 2008 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr314.93 Million | -4.08% |
| 2024-12-31 | Skr328.34 Million | -7.03% |
| 2023-12-31 | Skr353.18 Million | -28.75% |
| 2022-12-31 | Skr495.71 Million | -8.45% |
| 2021-12-31 | Skr541.45 Million | +45.02% |
| 2020-12-31 | Skr373.35 Million | -3.45% |
| 2019-12-31 | Skr386.69 Million | +4.28% |
| 2018-12-31 | Skr370.82 Million | -4.21% |
| 2017-12-31 | Skr387.11 Million | -0.83% |
| 2016-12-31 | Skr390.33 Million | -6.50% |
| 2015-12-31 | Skr417.44 Million | -19.52% |
| 2014-12-31 | Skr518.71 Million | +268.00% |
| 2013-12-31 | Skr140.95 Million | -2.52% |
| 2012-12-31 | Skr144.60 Million | -23.03% |
| 2011-12-31 | Skr187.86 Million | -35.80% |
| 2010-12-31 | Skr292.61 Million | -7.81% |
| 2009-12-31 | Skr317.39 Million | +3.31% |
| 2008-12-31 | Skr307.22 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bactiguard Holding AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 49104400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr876.00K | 0.28% |
| Other Comprehensive Income | Skr-1.44 Million | -0.46% |
| Other Components | Skr930.68 Million | 295.52% |
| Total Equity | Skr314.93 Million | 100.00% |
Bactiguard Holding AB (publ) Competitors by Market Cap
The table below lists competitors of Bactiguard Holding AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Panjawattana Plastic Public Company Limited
BK:PJW
|
$19.20 Million |
|
Likhitha Infrastructure Limited
NSE:LIKHITHA
|
$19.20 Million |
|
Future Battery Minerals Ltd
AU:FBM
|
$19.21 Million |
|
JSW Pacific
TWO:5251
|
$19.21 Million |
|
BACTIGUARD HLDG B
F:5JE
|
$19.18 Million |
|
Geekay Wires Limited
NSE:GEEKAYWIRE
|
$19.18 Million |
|
Zero Gravity Solutions Inc
PINK:ZGSI
|
$19.17 Million |
|
Asflow Co. Ltd.
KQ:159010
|
$19.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bactiguard Holding AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 328,342,000 to 314,933,000, a change of -13,409,000 (-4.1%).
- Net loss of 7,844,000 reduced equity.
- Other comprehensive income decreased equity by 5,565,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-7.84 Million | -2.49% |
| Other Comprehensive Income | Skr-5.57 Million | -1.77% |
| Total Change | Skr- | -4.08% |
Book Value vs Market Value Analysis
This analysis compares Bactiguard Holding AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.75x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.00x to 1.75x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | Skr31738.90 | Skr15.70 | x |
| 2010-12-31 | Skr29260.80 | Skr15.70 | x |
| 2011-12-31 | Skr18785.70 | Skr15.70 | x |
| 2012-12-31 | Skr14460.00 | Skr15.70 | x |
| 2013-12-31 | Skr14095.20 | Skr15.70 | x |
| 2014-12-31 | Skr20.74 | Skr15.70 | x |
| 2015-12-31 | Skr12.53 | Skr15.70 | x |
| 2016-12-31 | Skr11.72 | Skr15.70 | x |
| 2017-12-31 | Skr11.62 | Skr15.70 | x |
| 2018-12-31 | Skr11.14 | Skr15.70 | x |
| 2019-12-31 | Skr11.61 | Skr15.70 | x |
| 2020-12-31 | Skr11.13 | Skr15.70 | x |
| 2021-12-31 | Skr15.45 | Skr15.70 | x |
| 2022-12-31 | Skr14.15 | Skr15.70 | x |
| 2023-12-31 | Skr10.08 | Skr15.70 | x |
| 2024-12-31 | Skr9.37 | Skr15.70 | x |
| 2025-12-31 | Skr8.99 | Skr15.70 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bactiguard Holding AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -2.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.63%
- • Asset Turnover: 0.40x
- • Equity Multiplier: 1.73x
- Recent ROE (-2.49%) is above the historical average (-9.29%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 2.42% | 6.04% | 0.21x | 1.95x | Skr-24.07 Million |
| 2010 | -8.46% | -21.06% | 0.22x | 1.84x | Skr-54.01 Million |
| 2011 | -8.15% | -349.27% | 0.01x | 3.46x | Skr-34.09 Million |
| 2012 | -26.53% | -29.73% | 0.18x | 4.87x | Skr-52.82 Million |
| 2013 | -2.42% | -2.69% | 0.18x | 5.09x | Skr-17.50 Million |
| 2014 | -18.32% | -87.16% | 0.13x | 1.56x | Skr-146.91 Million |
| 2015 | -6.35% | -20.17% | 0.19x | 1.62x | Skr-68.25 Million |
| 2016 | -6.88% | -22.61% | 0.19x | 1.62x | Skr-65.88 Million |
| 2017 | -0.84% | -2.20% | 0.24x | 1.62x | Skr-41.96 Million |
| 2018 | -4.03% | -9.95% | 0.26x | 1.58x | Skr-52.01 Million |
| 2019 | 4.20% | 8.79% | 0.29x | 1.66x | Skr-22.41 Million |
| 2020 | -10.28% | -22.28% | 0.26x | 1.81x | Skr-75.72 Million |
| 2021 | -10.85% | -34.68% | 0.20x | 1.57x | Skr-112.92 Million |
| 2022 | -10.67% | -23.65% | 0.28x | 1.63x | Skr-102.45 Million |
| 2023 | -39.18% | -67.84% | 0.31x | 1.87x | Skr-173.70 Million |
| 2024 | -9.08% | -12.24% | 0.37x | 2.00x | Skr-62.65 Million |
| 2025 | -2.49% | -3.63% | 0.40x | 1.73x | Skr-39.34 Million |
Industry Comparison
This section compares Bactiguard Holding AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $44,313,585
- Average return on equity (ROE) among peers: -78.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bactiguard Holding AB (publ) (BACTI-B) | Skr314.93 Million | 2.42% | 0.73x | $19.20 Million |
| Acarix A/S (ACARIX) | $76.60 Million | -60.65% | 0.08x | $28.86 Million |
| Arcoma AB (ARCOMA) | $12.52 Million | -92.85% | 4.66x | $8.93 Million |
| CellaVision AB (CEVI) | $20.07 Million | 13.08% | 1.20x | $262.59 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $65.69 Million | -72.50% | 0.20x | $13.78 Million |
| Chordate Medical Holding AB (CMH) | $38.95 Million | -55.88% | 0.13x | $17.64K |
| Coala Life Group AB (COALA) | $52.33 Million | -287.99% | 0.53x | $468.93K |
| C-Rad AB (publ) (CRAD-B) | $93.64 Million | 22.63% | 0.57x | $56.67 Million |
| Duearity AB (DEAR) | $-2.39 Million | 0.00% | 0.00x | $34.43K |
| Episurf Medical AB (publ) (EPIS-B) | $41.40 Million | -170.53% | 0.39x | $5.40 Million |